![](/wp-content/themes/yootheme/cache/80/Iowa-804be7ef.jpeg)
Local Cdiff information for Iowa
Iowa
Learn about C. diff providers, regulation, clinical trials, and advocacy efforts in Iowa.
Local Cdiff information for Iowa
Iowa
Learn about C. diff providers, regulation, clinical trials, and advocacy efforts in Iowa.
![](/wp-content/themes/yootheme/cache/80/Iowa-804be7ef.jpeg)
Providers
Mary Greeley Medical Center
Mary Greeley Medical Center – GI Services Department
1111 Duff Avenue
Ames, 50010
(515) 239-2011
FMT Provider: Yes
Regulation
C. diff Infections
Total Reported Cases: 650
Hospital Onset: 650
Community Onset: Not reported
Related Deaths: Not reported
Available Reports
State Reporting Laws
Data Submission Required: No
Data Publicly Available: No
Data Validated: Yes
Facility-specific Data Publicly Reported: No
LTC Facility Submission Required: No
LTC Facility Data Publicly Reported: No
Law/Regulation: Not available
State Contact
Nancy Wilde
HAI Coordinator
Iowa Department of Public Health
Center for Acute Disease Epidemiology
321 East 12th Street
Des Moines, 50319
(515) 242-3892
(515) 281-5698
CLINICAL TRIALS
ROAR
Official Title: REBYOTA™ for the Prevention of Recurrence of Clostridioides Difficile Infection (CDI) in Adult Patients: An Observational Study
Trial No. NCT05835219
Type: Observational
Recruitment: Recruiting
Sponsor: Ferring Pharmaceuticals
Contact: Global Clinical Compliance
833-548-1402
Gender: All
Age: 18 Years and older
RESTORATiVE303
Official Title: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of VE303 for Prevention of Recurrent Clostridioides Difficile Infection
Trial No. NCT06237452
Type: Interventional
Recruitment: Recruiting
Sponsor: Vedanta Biosciences, Inc
Contact: Mary Garfield
Trial No. NCT06237452
Type: Interventional
Recruitment: Recruiting
Sponsor: Vedanta Biosciences, Inc
Contact: Mary Garfield
Gender: All
Age: 12 Years and older
Vedanta Biosciences has teamed up with Science37 to provide a site-less, decentralized approach. This means the study can be done remotely and the product comes to you, in your home. This allows applicants who are not near a study site or unable to travel to participate and receive treatment. You can sign up for the decentralized study here.